Yanjuan Xiong

A Phase IB Trial of Autologous Cytokine‐Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death‐1, plus Chemotherapy in Patients with Advanced Non‐Small‐Cell Lung Cancer

Li Zhou, Yanjuan Xiong, Yang Wang et al. · Clinical Lung Cancer · 2022 · 35 citations · Full text

A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial

Xiaobin Shang, Yongjie Xie, Jinpu Yu et al. · Cancer Cell · 2024 · 34 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +8

Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma

Yu Zheng, Baihui Li, Jian Wang et al. · Clinical Epigenetics · 2018 · 30 citations · Full text

T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human

Qian Sun, Xiying Zhang, Limei Wang et al. · Cell Death and Disease · 2019 · 22 citations · Full text

Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet

Yanjuan Xiong, Ning Zhao, Yu Zheng et al. · Tumor Biology · 2017 · 11 citations · Full text